|
1
|
Zuccari DAPC, Pavam MV, Terzian ACB,
Pereira RS, Ruiz CM and Andrade JC: Immunohistochemical evaluation
of e-cadherin, Ki-67 and PCNA in canine mammary neoplasias:
correlation of prognostic factors and clinical outcome. Pesquisa
Vet Brasil. 28:207–215. 2008.
|
|
2
|
Andrade FH, Figueiroa FC, Bersano PR,
Bissacot DZ and Rocha NS: Malignant mammary tumor in female dogs:
environmental contaminants. Diagn Pathol. 5:452010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chu PY, Hsu NC, Liao AT, Shih NY, Hou MF
and Liu CH: Overexpression of α-enolase correlates with poor
survival in canine mammary carcinoma. BMC Vet Res. 7:622011.
View Article : Google Scholar
|
|
4
|
Klopfleisch R, von Euler H, Sarli G, Pinho
SS, Gärtner F and Gruber AD: Molecular carcinogenesis of canine
mammary tumors: news from an old disease. Vet Pathol. 48:98–116.
2011. View Article : Google Scholar
|
|
5
|
Michel E, Feldmann SK, Kowalewski MP, Bley
CR, Boos A, Guscetti F and Reichler IM: Expression of prolactin
receptors in normal canine mammary tissue, canine mammary adenomas
and mammary adenocarcinomas. BMC Vet Res. 8:722012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yoshikawa Y, Morimatsu M, Ochiai K, et al:
Establishment of a PCR analysis method for canine BRCA2. BMC Res
Notes. 5:1732012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gelaleti GB, Jardim BV, Leonel C,
Moschetta MG and Zuccari DA: Interleukin-8 as a prognostic serum
marker in canine mammary gland neoplasias. Vet Immunol
Immunopathol. 146:106–112. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Phillips JC, Lembcke L and Chamberlin T: A
novel locus for canine osteosarcoma (OSA1) maps to CFA34, the
canine orthologue of human 3q26. Genomics. 96:220–227. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Levalle GE, Bertagnolli AC, Tavares WL and
Cassali GD: Cox-2 expression in canine mammary carcinomas:
correlation with angiogenesis and overall survival. Vet Pathol.
46:1275–1280. 2009. View Article : Google Scholar
|
|
10
|
Abreu E and Koifman S: Fatores
prognósticos no câncer da mama feminina. Rev Bras Cancerol.
48:113–131. 2002.
|
|
11
|
Rakha EA, Reis-Filho JS and Ellis IO:
Combinatorial biomarker expression in breast cancer. Breast Cancer
Res Treat. 120:293–308. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jardim-Perassi BV, Arbab AS, Ferreira LC,
et al: Effect of melatonin in tumor growth and angiogenesis in
xenograft modelo f breast cancer. PLoS One. 9:e853112014.
View Article : Google Scholar
|
|
13
|
Roberts E, Cossigny DA and Quan GM: The
role of vascular endothelial growth factor in metastatic prostate
cancer to the skeleton. Prostate Cancer. 2013:4183402013.
View Article : Google Scholar
|
|
14
|
Gavalas NG, Liontos M, Trachana SP, et al:
Angiogenesis-related pathways in the pathogenesis of ovarian
cancer. Int J Mol Sci. 14:15885–15909. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Romon R, Adriaenssens E, Lagadec C,
Germain E, Hondermarck H and Le Bourhis X: Nerve growth factor
promotes breast cancer angiogenesis by activating multiple
pathways. Mol Cancer. 9:1572010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Greenberg S and Rugo HS: Triple-negative
breast cancer: role of antiangiogenic agents. Cancer J. 16:33–38.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Arbab AS: Activation of alternative
pathways of angiogenesis and involvement of stem cells following
anti-angiogenesis treatment in glioma. Histol Histopathol.
27:549–557. 2012.PubMed/NCBI
|
|
18
|
Sadri N and Zhang PJ: Hypoxia-inducible
factors: mediators of cancer progression; prognostic and
therapeutic targets in soft tissue sarcomas. Cancers. 5:320–333.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tung KH, Lin CW, Kuo CC, et al: CHC
promotes tumor growth and angiogenesis through regulation of HIF-1α
and VEGF signaling. Cancer Lett. 331:58–67. 2013. View Article : Google Scholar
|
|
20
|
Semenza GL: HIF-1 and tumor progression:
pathophysiology and therapeutics. Trends Mol Med. 8(Suppl 4):
62–66. 2002. View Article : Google Scholar
|
|
21
|
Yang L, Zhao W, Zuo WS, et al: Silencing
of osteopontin promotes the radiosensitivity of breast cancer cells
by reducing the expression of hypoxia inducible factor 1 and
vascular endothelial growth factor. Chin Med J. 125:293–299.
2012.PubMed/NCBI
|
|
22
|
Aranha AMF: Potencial angiogênico de
células pulpares humanas em hipóxia. Araraquara: Universidade
Estadual Paulista - Faculdade de Odontologia de Araraquara.
Dissertação (Doutorado). Programa de Pós-Graduação em Ciências
Odontológicas; Araraquara, São Paulo: 2008
|
|
23
|
Harris AL: Hypoxia - a key regulatory
factor in tumour growth. Nat Rev Cancer. 2:38–47. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li XR, Liu M, Zhang YJ, et al: ER, PgR,
HER-2, Ki-67, topoisomerase IIα, and nm23-H1 proteins expression as
predictors of pathological complete response to neoadjuvant
chemotherapy for locally advanced breast cancer. Med Oncol.
28(Suppl 1): 48–54. 2011. View Article : Google Scholar
|
|
25
|
Kallergi G, Markomanolaki H, Giannoukaraki
V, et al: Hypoxia-inducible factor-1alpha and vascular endothelial
growth factor expression in circulating tumor cells of breast
cancer patients. Breast Cancer Res. 11:R842009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Brito LG, Schiavon VF, Andrade JM, Tiezzi
DG, Peria FM and Marana HR: Expression of hypoxia-inducible factor
1-α and vascular endothelial growth factor-C in locally advanced
breast cancer patients. Clinics. 66:1313–1320. 2011.
|
|
27
|
Higashimura Y, Nakajima Y, Yamaji R, et
al: Up-regulation of glyceraldehyde-3-phosphate dehydrogenase gene
expression by HIF-1 activity depending on Sp1 in hypoxic breast
cancer cells. Arch Biochem Biophys. 509:1–8. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ji B, Liu Y, Zhang P, Wang Y and Wang G:
COX-2 expression and tumor angiogenesis in thyroid carcinoma
patients among northeast Chinese population-result of a
single-center study. Int J Med Sci. 9:237–242. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ferrara N: Vascular endothelial growth
factor and age-related macular degeneration: from basic science to
therapy. Nat Med. 16:1107–1111. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kato Y, Asano K, Mogi T, et al: Clinical
significance of circulating vascular endothelial growth factor in
dogs with mammary gland tumors. J Vet Med Sci. 69:77–80. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Pande D, Negi R, Khanna S, Khanna R and
Khanna HD: Vascular endothelial growth factor levels in relation to
oxidative damage and antioxidant status in patients with breast
cancer. J Breast Cancer. 14:181–184. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Taneja P, Maglic D, Kai F, et al:
Classical and novel prognostic markers for breast cancer and their
clinical significance. Clin Med Insights Oncol. 4:15–34.
2010.PubMed/NCBI
|
|
33
|
Zhang J, Lu A, Li L, Yue J and Lu Y: p16
modulates VEGF expression via its interaction with HIF-1alpha in
breast cancer cells. Cancer Invest. 28:588–597. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Koukourakis MI, Limberis V, Tentes I, et
al: Serum VEGF levels and tissue activation of VEGFR2/KDR receptors
in patients with breast and gynecologic cancer. Cytokine.
53:370–375. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Qui CW, Lin DG, Wang JQ, Li CY and Deng
GZ: Expression and significance of PTEN and VEGF in canine mammary
gland tumours. Vet Res Commun. 32:463–472. 2008. View Article : Google Scholar
|
|
36
|
Al-Dissi AN, Haines DM, Singh B and Kidney
BA: Immunohistochemical expression of vascular endothelial growth
factor and vascular endothelial growth factor receptor-2 in canine
simple mammary gland adenocarcinomas. Can Vet J. 51:1109–1114.
2010.
|
|
37
|
Millanta F, Caneschi FV, Ressel L, Citi S
and Poli A: Expression of vascular endothelial growth factor in
canine inflammatory and non-inflammatory mammary carcinoma. J Comp
Pathol. 142:36–42. 2010. View Article : Google Scholar
|
|
38
|
Misdorp W, Else RW, Hellmén E and Lipscomb
E: Definitions and explanatory notes. Who Histological
Classification of Mammary Tumors of the Dog and Cat Washington:
Armed Forces Institute of Pathology; pp. 18–27. 1999
|
|
39
|
Cassali GD, Lavalle GE, De Nardi AB, et
al: Consensus for the diagnosis, prognosis and treatment of canine
mammary tumors. Braz J Vet Pathol. 2:153–180. 2011.
|
|
40
|
Owen LN: The TNM Classification of tumors
in domestic animals. 1st. Geneva: World Health Organization;
1980
|
|
41
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative CT method. Nat Protoc.
3:1101–1108. 2008. View Article : Google Scholar
|
|
42
|
Maschio LB, Madallozo BB, Capellasso BA,
et al: Immunohistochemical investigation of the angiogenic proteins
VEGF, HIF-1α and CD34 in invasive ductal carcinoma of the breast.
Acta Histochem. 116:148–157. 2014. View Article : Google Scholar
|
|
43
|
Kim HS, Park YH, Park MJ, et al: Clinical
significance of a serum CA15-3 surge and the usefulness of CA15-3
kinetics in monitoring chemotherapy response in patients with
metastatic breast cancer. Breast Cancer Res Treat. 118:89–97. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Hodorowicz-Zaniewska D, Kibil W, Małek A,
Szpor J, Kulig J and Sztefko K: Evaluation of serum concentrations
of vascular endothelial growth factor (VEGF) in breast cancer
patients. Pol J Pathol. 63:255–260. 2012. View Article : Google Scholar
|
|
45
|
Spencer L, Mann C, Metcalfe M, et al: The
effect of omega-3 FAs on tumour angiogenesis and their therapeutic
potential. Eur J Cancer. 45:2077–2086. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Jia D, Hasso SM, Chan J, et al:
Transcriptional repression of VEGF by ZNF24: mechanistic studies
and vascular consequences in vivo. Blood. 121:707–715. 2013.
View Article : Google Scholar :
|
|
47
|
Kapahi R, Manjari M, Uppal MS, Singh NR,
Sambyal V and Guleria K: Association of -2549 insertion/deletion
polymorphism of vascular endothelial growth factor with breast
cancer in North Indian patients. Genet Test Mol Biomarkers.
17:242–248. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Duranyildiz D, Camlica H, Soydinc HO,
Derin D and Yasasever V: Serum levels of angiogenic factors in
early breast cancer remain close to normal. Breast. 18:26–29. 2009.
View Article : Google Scholar
|
|
49
|
El Tarhouny S, Seefeld M, Fan AX, Hahn S,
Holzgreve W and Zhong XY: Comparison of serum VEGF and its soluble
receptor sVEGFR1 with serum cell-free DNA in patients with
breasttumor. Cytokine. 44:65–69. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Thielemann A, Baszczuk A, Kopczyński Z,
Kopczyński P and Grodecka-Gazdecka S: Clinical usefulness of
assessing VEGF and soluble receptors sVEGFR-1 and sVEGFR-2 in women
with breast cancer. Ann Agric Environ Med. 20:293–297.
2013.PubMed/NCBI
|
|
51
|
Coskun U, Günel N, Toruner FB, et al:
Serum leptin, prolactin and vascular endothelial growth factor
(VEGF) levels in patients with breast cancer. Neoplasma. 50:41–46.
2003.PubMed/NCBI
|
|
52
|
Perez-Rivas LG, Jerez JM, Fernandez-De
Sousa CE, et al: Serum protein levels following surgery in breast
cancer patients: A protein microarray approach. Int J Oncol.
41:2200–2206. 2012.PubMed/NCBI
|
|
53
|
Milani M and Harris AL: Targeting tumour
hypoxia in breast cancer. Eur J Cancer. 44:2766–2773. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Flamant L, Notte A, Ninane N, Raes M and
Michiels C: Anti-apoptotic role of HIF-1 and AP-1 in paclitaxel
exposed breast cancer cells under hypoxia. Mol Cancer. 9:1912010.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Ece H, Cigdem E, Yuksel K, Ahmet D, Hakan
E and Oktay TM: Use of oral antidiabetic drugs (metformin and
pioglitazone) in diabetic patients with breast cancer: how does it
affect serum Hif-1 alpha and 8Ohdg levels? Asian Pac J Cancer Prev.
13:5143–5148. 2012. View Article : Google Scholar
|
|
56
|
De Francesco EM, Lappano R, Santolla MF,
Marsico S, Caruso A and Maggiolini M: HIF-1α/GPER signaling
mediates the expression of VEGF induced by hypoxia in breast cancer
associated fibroblasts (CAFS). Breast Cancer Res. 15:R642013.
View Article : Google Scholar
|
|
57
|
Liang J, Qian Y, Xu D, Yin Q and Pan HJ:
Serum tumor markers, hypoxia-inducible factor-1α HIF-1α and
vascular endothelial growth factor, in patients with non-small cell
lung cancer before and after intervention. Asian Pac J Cancer Prev.
14:3851–3854. 2013. View Article : Google Scholar
|
|
58
|
Restucci B, Borzacchiello G, Maiolino P,
Martano M, Paciello O and Papparella S: Expression of vascular
endothelial growth factor receptor Flk-1 in canine mammary tumours.
J Comp Pathol. 130:99–104. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Ramanathan M, Pinhal-Enfield G, Hao I and
Leibovich SJ: Synergistic up-regulation of vascular endothelial
growth factor (VEGF) expression in macrophages by adenosine A2A
receptor agonists and endotoxin involves transcriptional regulation
via the hypoxia response element in the VEGF promoter. Mol Biol
Cell. 18:14–23. 2007. View Article : Google Scholar :
|
|
60
|
Mohammed RA, Green A, El-Shikh S, Paish
EC, Ellis IO and Martin SG: Prognostic significance of vascular
endothelial cell growth factors -A, -C and -D in breast cancer and
their relationship with angio- and lymphangiogenesis. Br J Cancer.
96:1092–1100. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Santos AA, Oliveira JT, Lopes CC, Amorim
IF, Vicente CM, Gärtner FR and Matos AJ: Immunohistochemical
expression of vascular endothelial growth factor in canine mammary
tumours. J Comp Pathol. 143:268–275. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Mimeault M and Batra SK: Hypoxia-inducing
factors as master regulators of stemness properties and altered
metabolism of cancer and metastasis initiating cells. J Cell Mol
Med. 17:30–54. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Yamamoto Y, Ibusuki M, Okumura Y, Kawasoe
T, Kai K, Iyama K and Iwase H: Hypoxia-inducible factor 1alpha is
closely linked to an aggressive phenotype in breast cancer. Breast
Cancer Res Treat. 110:465–475. 2008. View Article : Google Scholar
|
